The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Mitochondrial disorders are caused by gene mutations in mitochondrial or nuclear DNA and affect energy-dependent organs such as the brain. Patients with psychiatric illness, particularly those with medical comorbidities, may have primary mitochondrial disorders. To date, this issue has received little attention in the literature, and mitochondrial disorders are likely underdiagnosed in psychiatric patients. DATA SOURCES: This article describes a patient who presented with borderline personality disorder and treatment-resistant depression and was ultimately diagnosed with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) 3271. We also searched the literature for all case reports of patients with mitochondrial disorders who initially present with prominent psychiatric symptoms by using MEDLINE (from 1948-February 2011), Embase (from 1980-February 2011), PsycINFO (from 1806-February 2011), and the search terms mitochondrial disorder, mitochondria, psychiatry, mental disorders, major depression, anxiety, schizophrenia, and psychosis. STUDY SELECTION: Fifty cases of mitochondrial disorders with prominent psychiatric symptomatology were identified. DATA EXTRACTION: Information about the psychiatric presentation of the cases was extracted. This information was combined with our case, the most common psychiatric manifestations of mitochondrial disorders were identified, and the important diagnostic and treatment implications for patients with psychiatric illness were reviewed. RESULTS: The most common psychiatric presentations in the cases of mitochondrial disorders included mood disorder, cognitive deterioration, psychosis, and anxiety. The most common diagnosis (52% of cases) was a MELAS mutation. Other genetic mitochondrial diagnoses included polymerase gamma mutations, Kearns-Sayre syndrome, mitochondrial DNA deletions, point mutations, twinkle mutations, and novel mutations. CONCLUSIONS: Patients with mitochondrial disorders can present with primary psychiatric symptomatology, including mood disorder, cognitive impairment, psychosis, and anxiety. Psychiatrists need to be aware of the clinical features that are indicative of a mitochondrial disorder, investigate patients with suggestive presentations, and be knowledgeable about the treatment implications of the diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have shown that psychiatric illnesses are common in patients with mitochondrial diseases. 3 , 4 , 5 , 6”
From Psychiatric care for a person with MELAS syndrome: A case report (2021) · cites this paper as [3]
In the citing paper
“and these include SSRIs, 12 , 14 , 15 SNRIs, 3 MAOIs, 4 antipsychotics, 16 , 17 , 18 and sodium‐valproate 19 , 20 , 21 , 22”
From Psychiatric care for a person with MELAS syndrome: A case report (2021) · cites this paper as [3]
Citations
Cites
Still being checked.
Cited by
Items 101–150 of 150
Rappeneau, V., Koti, P. S., Wilmes, L., Widner-Andrä, R., Busch, K. B., & Touma, C. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16044 · Cited by 5
Mitochondrial Dysfunction in Psychiatric Disorders
Rossignol, D. A., & Frye, R. E. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_12 · Cited by 6
Oxidative stress as a problem of psychopharmacology
Arushanyan, E., & Наумов, С. С. (2020) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf184297-311 · Cited by 4
Catatonia as prominent feature of stroke-like episode in MELAS
Montano, V., Simoncini, C., LoGerfo, A., Siciliano, G., & Mancuso, M. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04638-5 · Cited by 4
Ndufs4 KO mice: A model to study comorbid mood disorders associated with mitochondrial dysfunction
van Rensburg, D. J., Lindeque, J. Z., Harvey, B. H., & Steyn, S. F. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173689 · Cited by 5
Mitochondrial Etiology of Psychiatric Disorders: Is This the Full Story?
Kozicz, T., Schene, A. H., & Morava, É. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0018 · Cited by 4
A new opportunity: metabolism and neuropsychiatric disorders
Kozicz, T., & Morava, É. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0215-y · Cited by 4
Smedler, E., Salehi, A. M., Pelanis, A., Andreazza, A. C., Pålsson, E., Sparding, T., & Landén, M. (2022) · Neuroscience Applied · doi:10.1016/j.nsa.2022.100108 · Cited by 8
Tres preguntas y una respuesta: algoritmo diagnóstico molecular en enfermedades mitocondriales
Kauffman, M. (2012) · Neurología Argentina · doi:10.1016/j.neuarg.2012.10.002 · Cited by 3
Mitochondrial dysfunction and affective disorders: Focus on diet, exercise, and aging
Allen, J., Kalynchuk, L. E., & Caruncho, H. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00017-6 · Cited by 3
Biomarkers For the Diagnosis of Depression: Recent Updates
Kore, M. S., & Prabhavalkar, K. S. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082219666221114114738 · Cited by 4
Psychiatric care for a person with MELAS syndrome: A case report
Leong, D. Y., Chee, R. Y., & Lui, Y. S. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4146 · Cited by 2
Bulduk, B. K., Tortajada, J., Torres-Egurrola, L., Valiente-Pallejà, A., Martínez‐Leal, R., Vilella, E., Torrell-Galceran, H., Muntané, G., & Martorell, L. (2024) · Journal of Intellectual Disability Research · doi:10.1111/jir.13197 · Cited by 3
Single-molecule DNA analysis implicates brain mitochondria pathology in bipolar disorder
Ohtani, H., Ichikawa, R., Mori, K., Kato, T., & Nishioka, M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03071-4 · Cited by 4
Molecular basis of neurocognitive dysfunction and psychosis in Alpha-Mannosidosis
Dewsbury, M., Hargreaves, I. P., Morgan, H. M., & Stępień, K. M. (2024) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2023.58 · Cited by 4
Malingering and Factitious Disorder (Münchausensyndrome) can be Mitochondrial
Finsterer, J., & Lässer, S. (2016) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.185947 · Cited by 2
Schizophrenia-Like Psychotic Symptoms Associated to Leigh Syndrome
Jaballah, F., Nouira, R. B. S., Mallouli, S. Z., Boussaid, H., Younes, S., Zarrouk, L., & Younes, S. (2023) · Case Reports in Psychiatry · doi:10.1155/2023/8886555 · Cited by 3
Benisty, S., & Chabriat, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-49586-2_7 · Cited by 2
Beekhuis-Hoekstra, S. D., Laupman, K. E., Wei, Y., Watanabe, K., Cornelissen‐Steijger, P., Sullivan, P. F., Posthuma, D., & Heine, V. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1811182/v1 · Cited by 2
Finkener, S., Ovchinnikov, A., Bauer, R. L., Diepers, M., & Gschwind, M. (2024) · Clinical and Translational Neuroscience · doi:10.3390/ctn8040030 · Cited by 1
Watchalotone, S., McDonald, H. M., Degolier, J., Schlangen, A., & Ahmed, I. (2024) · Cureus · doi:10.7759/cureus.75268 · Cited by 1
Differential Diagnosis of Abnormal Symptoms and Signs
Ettinger, A. B., & Weisbrot, D. M. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139028899.003 · Cited by 1
Mitochondrial genetics and bipolar disorder
Konradi, C. L., & Kato, T. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197574522.003.0014 · Cited by 1
Psychosis Caused by a Somatic Condition: How to Make the Diagnosis? A Systematic Literature Review
Dissaux, N., Neyme, P., Kim-Dufor, D.-H., Lavenne-Collot, N., Marsh, J. J., Berrouiguet, S., Walter, M., & Lemey, C. (2023) · Children · doi:10.3390/children10091439 · Cited by 2
Sheng, X., & Wang, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4167 · Cited by 1
Modern neurogenetic representations of MELAS syndrome. Clinical cases (the lecture)
Shatalin, A. V., Мухина, Е. В., Котов, А. С., & Грантович, А. М. (2020) · Russian Journal of Child Neurology · doi:10.17650/2073-8803-2019-14-4-26-31 · Cited by 1
Antidepressants, mood-stabilizing drugs, and mitochondrial functions: For better or for worse
Preston, G. J., Sabbagh, D. E. S. E., Emmerzaal, T. L., Morava, É., Andreazza, A. C., Rahman, S., & Kozicz, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88462-4.00016-x · Cited by 1
63 congreso Nacional de la Asociación Española de Psiquiatría del Niño y del Adolescente
Aepnya, R. (2019) · Revista de Psiquiatría Infanto-Juvenil · doi:10.31766/revpsij.v36n2 · Cited by 1
Diagnostic Challenges in Mitochondrial Disease
Dabke, P., & Rao, P. (2012) · International Journal of Health and Rehabilitation Sciences (IJHRS) · doi:10.5455/ijhrs.00000005
Acebrón, F., Martín, C. A., Barroeta, A. D. A.-C., Rubio, C., Torre, P. P., Luengo, A. V., Corral, Í., Cánovas, A. A., & Rodríguez, J. O. (2015) · Psiquiatría Biológica · doi:10.1016/j.psiq.2015.10.006
Mitochondrial Dysfunction and Physiological Depression
Raffelock, D. (2015) · CRC Press eBooks · doi:10.1201/b19089-7
Clinical Genetic Testing and Counseling in Psychiatry
Bouwkamp, C. G., Afawi, Z., & Kushner, S. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813335-4.00011-8
Effect of Selective Serotonin-Noradrenaline Reuptake Inhibitors on Mitochondrial Functionn
Finsterer, J., & Zarrouk‐Mahjoub, S. (2017) · Avicenna Journal of Neuro Psych Physiology · doi:10.32598/ajnpp.4.4.129
Inflammation and Mitochondrial Dysfunction in Type I Bipolar Disorder
Pan, A. (2017) · TSpace (University of Toronto)
Psychiatric Symptoms Associated with Inborn Errors of Metabolism
Turkel, S. B., Wong, D. A., & Randolph, L. M. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00403-z · Cited by 1
Meningioma Infiltrative Accompanied by Organic Delusional Disorders
Asmedi, A. (2021) · Scientia Psychiatrica · doi:10.37275/scipsy.v2i1.28
Ertl, M., Fettweis, C., Braadt, L., Maurer, C., & Naumann, M. (2021) · DGNeurologie · doi:10.1007/s42451-021-00343-5
The Neurobiology and Treatment of Bipolar Disorder
Burdick, K. E., Ospina, L. H., Haggarty, S. J., & Perlis, R. H. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0020 · Cited by 1
Lorazepam/perphenazine/sertraline
(2015) · Reactions Weekly · doi:10.1007/s40278-015-1624-4
Lithium modulates energy metabolism in the frontal cortex of rats treated with ketaminePreprint
Budni, J., Medeiros, E. B., Silveira, G. B., Lídio, A. V., Zabot, G. C., Resende, W. R., Dal-Pont, G. C., Maciel, A. L., Freitas, K. V., Generoso, J. S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5236333/v1
Examining mitochondrial genetic variation in obsessive-compulsive disorderPreprint
Gonçalves, V. F., Santos, F. C. D., Giannoulis, S., Lisoway, A. J., Wong, C., Zai, C. C. H., Zai, G. C., Kennedy, J. L., & Richter, M. A. (2025) · Research Square · doi:10.21203/rs.3.rs-6149169/v1
Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder
Kondo, K., Yoshino, Y., Kumon, H., Okano, M., Mori, H., Iga, J., & Ueno, S. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251337365
Sabbagh, D. E. S. E., Choi, J., Balachandar, L., Haydarian, E., Demyati, J., Mazhar, Z., Duong, A., Bortolasci, C. C., Irwin, C., Singh, K. K., et al. (2026) · Neurobiology of Disease · doi:10.64898/2025.12.19.695603
Yang, R., Chen, X., Tan, G., Yang, J., Du, J., Li, J. W., Li, W., Wang, H., Zhu, H., Yuan, M., et al. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07798-4
Riquin, É. (2021) · theses.fr (ABES) · doi:10.70675/ac08dac0z6298z4208z940dz744dbd9b029f · Cited by 1
Colijn, M. A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111739
OTUD1 promotes the progession of depression through mitochondrial damage by targeting MST1/2
Wang, C., Huang, D., Wang, J., Wang, X., Tao, G., Shan, H., Liu, W., Ding, Y., & Ding, S. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106846 · Cited by 1
Andreazza, A. C., Barrett, L. F., Behnke, A., Bolaños, J. P., de Juan‐Sanz, J., Epel, E., Evans, M. K., Gyllenhammer, L. E., Hirabayashi, Y., Hirano, M., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107036
Antidepressants, mood-stabilizing drugs, and mitochondrial function: For better or for worse
Preston, G. J., Sabbagh, D. E. S. E., Emmerzaal, T. L., Morava, É., Andreazza, A. C., Rahman, S., & Kozicz, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45078-5.00040-3
Crystal, H., & Rojas-Soto, D. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139028899.017
Metadata
- Authors
- Anglin, R. E., Garside, S. L., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I.
- Affiliations
- McMaster University (CA)
- Corresponding author
- Anglin, Rebecca E.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2012-04-15
- Volume
- 73
- Issue
- 04
- Pages
- 506-512
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2045758444
- Cited by
- 150
- References
- 0
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 12 · 2023: 9 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 11 · 2018: 11 · 2017: 14 · 2016: 6 · 2015: 12 · 2014: 12 · 2013: 9 · 2012: 8
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- mitochondrial disease, psychiatric symptoms, MELAS, mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes, borderline personality disorder, treatment-resistant depression, mood disorders, psychosis, anxiety, cognitive impairment, Kearns-Sayre syndrome, mitochondrial DNA deletions, underdiagnosis
- MeSH terms
- Mental Disorders, Bipolar Disorder, Brain, Depressive Disorder, Female, Humans, Magnetic Resonance Imaging, Middle Aged, MELAS Syndrome, Mitochondrial Diseases, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.